Last reviewed · How we verify
Clinical and Molecular Phenotypes of Severe Asthma (SARP)
The mission of SARP is to improve the understanding of severe asthma through integrated study of its clinical and biological features and to evaluate their changes over time. The ultimate goal of these efforts is to promote better treatments for severe asthma.
Details
| Lead sponsor | University of California, San Francisco |
|---|---|
| Status | COMPLETED |
| Enrolment | 151 |
| Start date | 2012-11 |
| Completion | 2021-03-01 |
Conditions
- Asthma
Primary outcomes
- Lung function decline — Enrollment, 1 year, 2 years, 3 years
Changes in lung function parameters over time.
Countries
United States